ICG dye helps surgeons remove tumors
Treatments studied
Part of Blood & lymphatic, Cancer, Digestive system, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This early-phase study tests whether a special dye can help doctors see a tumor more clearly during surgery in children and young people. If you have a solid tumor or certain lymphomas that need removal, the dye may help guide the surgeon to the right tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have a primary or relapsed solid tumor or lymphoma that needs to be surgically removed.
- You are able and willing to give consent (or your legal guardian/representative can) in writing.
- Your tumor is not benign (not a non-cancer condition).
- Your tumor is not in the brain.
- You are not allergic to iodide (which the dye may relate to).
- You are not pregnant (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
Hear when a new Neoplastic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.